Equity MRK
Tuesday, April 13, 2021   
Asian Paints  2571.50    (-1.12%)
 
Axis Bank  661.25    (4.08%)
 
Bajaj Auto  3599.50    (1.63%)
 
Bajaj Finance  4727.40    (4.75%)
 
Bajaj Finserv  9809.95    (7.07%)
 
Bharti Airtel  536.00    (2.61%)
 
Dr Reddy's Lab...  4780.60    (-4.18%)
 
H D F C  2512.25    (3.78%)
 
HCL Technologi...  981.85    (-2.70%)
 
HDFC Bank  1400.30    (2.47%)
 
Hind. Unilever  2455.80    (-0.19%)
 
ICICI Bank  560.45    (4.10%)
 
IndusInd Bank  880.65    (4.29%)
 
Infosys  1398.60    (-1.91%)
 
ITC  208.70    (1.63%)
 
Kotak Mah. Ban...  1775.85    (1.93%)
 
Larsen & Toubr...  1373.50    (2.11%)
 
M & M  811.65    (8.02%)
 
Maruti Suzuki  6818.45    (4.60%)
 
Nestle India  17162.15    (-1.91%)
 
NTPC  100.45    (1.52%)
 
O N G C  102.05    (4.08%)
 
Power Grid Cor...  208.90    (3.88%)
 
Reliance Indus...  1931.90    (1.08%)
 
St Bk of India  340.95    (3.70%)
 
Sun Pharma.Ind...  627.40    (1.33%)
 
TCS  3105.00    (-4.21%)
 
Tech Mahindra  1001.30    (-3.54%)
 
Titan Company  1530.65    (1.48%)
 
UltraTech Cem.  6604.80    (1.53%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Hot Pursuit
Alembic Pharma rises after USFDA approval for antifungal drug
(11:56, 08 Apr 2021)
Alembic Pharma on Thursday announced that its joint venture Aleor Dermaceuticals (Aleor) has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for efinaconazole topical solution.

Efinaconazole topical solution is used to treat fungal toenail infections (infections that may cause nail discoloration, splitting, or pain). Efinaconazole topical solution is in a class of medications called antifungals. The product has an estimated market size of $233 million for twelve months ending December 2020 according to IQVIA.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution of Bausch Health Americas, Inc. Aleor has settled the case with Bausch Health and will launch its generic as per the terms of settlement.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world. The drug maker reported 13.8% jump in consolidated net profit to Rs 259.20 crore on a 8.7% rise in net sales to Rs 1,314.33 crore in Q3 FY21 over Q3 FY20.

Powered by Capital Market - Live News